Nicotine Containing Dental Floss
Keep away cavities and cancer at the same time.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7256204 | Amine compounds, their production and use A compound of the formula: wherein Ar is an aromatic ring assembly group which may be substituted or a fused aromatic group which may be substituted; X is (i) a bond, (ii) —S—, —SO— or —SO2â€... | 08/14/2007 |
| 6979566 | Method of treatment of viral infection including HIV using water soluble fullerenes—III A water soluble derivative of buckministerfullerene (C50) having antiviral and virucidal properties is used to inhibit human retroviral replication and infections. The derivatized fullerene is symmetrically substituted with polar organic moieties containi... | 12/27/2005 |
| 6787570 | Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted N-Alkyl/Alkenyl/Cycloalkyl/Heterocycyl N-Aryl/Heteroaryl tertiary-Heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and metho... | 09/07/2004 |
| 6710089 | Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atheroscle... | 03/23/2004 |
| 6677375 | Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating... | 01/13/2004 |
| 6653508 | 3-amino-2-benzyl-1-phenylpropane derivatives Substituted 3-amino-2-benzyl-1-phenlypropane derivatives, methods for preparing them, pharmaceutical compositions containing them, and methods of using them to treat various medical conditions.... | 11/25/2003 |
| 6613805 | Amine compounds, their production and use A compound of the formula: ##STR1## wherein Ar is an aromatic ring assembly group which may be substituted or a fused aromatic group which may be substituted; X is (i) a bond, (ii) --S--, --SO-- or --SO2 --, (iii) C1-6 alkylene, C | 09/02/2003 |
| 6583183 | Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating... | 06/24/2003 |
| 6521667 | Calcilytic compounds The present invention features calcilytic compounds. "Calcilytic compounds" refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial e... | 02/18/2003 |
| 6476075 | Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating... | 11/05/2002 |
| 6448295 | Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating... | 09/10/2002 |
| 6342532 | Inorganic ion receptor active compounds The present invention features compounds able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders using such compounds. Preferred compounds can mimic or block the effect of extracellular calcium o... | 01/29/2002 |
| 6313175 | Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor Novel meta substituted arylalkylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin mediated nerve transmission (e.g., depression and obesity).... | 11/06/2001 |
| 6310107 | Amine compounds, their production and use as amyloid-ଲ production inhibitors A compound of the formula: ##STR1## wherein Ar is an aromatic ring assembly group which may be substituted or a fused aromatic group which may be substituted; X is (i) a bond, (ii) --S--, --SO-- or --SO2 --, (iii) C1-6 alkylene, C | 10/30/2001 |
| 6204391 | Water soluble fullerenes with antiviral activity A water soluble derivative of buckministerfullerene (C60) having antiviral and virucidal properties is used to inhibit human retroviral replication and infections. The derivatized fullerene is symmetrically substituted with polar organic moieti... | 03/20/2001 |
| 6057371 | Sigma receptor ligands and the use thereof The invention relates to methods for the treatment of central nervous system disorders, gastrointestinal disorders, drug abuse, angina, migraine, hypertension and depression by administering a pharmaceutical composition comprising an effective amount of c... | 05/02/2000 |
| 5981599 | Inorganic ion receptor active compounds The present invention features compounds able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders using such compounds. Preferred compounds can mimic or block the effect of extracellular calcium o... | 11/09/1999 |
| 5756769 | Method for producing propargylamine compounds A method for producing a propargylamine compound represented by the general formula (I): ##STR1## which comprises reacting a propargyl compound represented by the general formula (II): ##STR2## with an aromatic aldehyde represented by the g... | 05/26/1998 |
| 5672738 | Process for the preparation of 3-(N-aryl-amino)-propyl-2'-sulfatoethyl-sulfonyl compounds Process for the preparation of 3-(N-aryl-amino)-propyl-2'-sulfatoethyl-sulfonyl compounds Compounds of the formula (1) Ar--NH--(CH2)3 --SO2 --(CH2)2 --OSO3 M(1) are prepared by reacting a compound of... | 09/30/1997 |
| 5648541 | Chiral reductions of imines leading to the syntheses of optically active amines A process for preparing an R enantiomer of a compound of the formula (I): ##STR1## wherein Ar is 3-methoxyphenyl, 3-chlorophenyl, or 1-naphthyl, and X is independently selected from the group consisting of H, F, Cl, Br, I, phenyl, CF3, CF | 07/15/1997 |
| 5616803 | Substituted amic acid derivatives A compound of the formula (I) or its pharmaceutically acceptable salt or ester: ##STR1## wherein each of the substituents are herein defined.... | 04/01/1997 |
| 5519062 | 1-alkyl, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds Novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates and processes for the preparation thereof, and methods of reducing inflammation and cell proliferation, and relieving memory dysfunction, and inhibiting bacterial and fu... | 05/21/1996 |
| 5508306 | Aromatic amine derivatives This invention relates to novel aromatic amine compounds having the structure: ##STR1## where each W, Z1 and Z2 is independently H, C1 -C6 alkyl, C1 -C6 alkoxy, OH, F, Cl, Br, I, NO | 04/16/1996 |
| 5504253 | Amine preparation A method of making (R)-N- 1-(3-methoxyphenyl)ethyl!-3-(2-chlorobenzene)propanamine which involves reducing the appropriate amidyl or iminyl precursor with an appropriate reducing agent. The appropriate amidyl or iminyl precursor is made from a synthe... | 04/02/1996 |
| 5326784 | Cycloalkylalkylamines which are sigma-receptor ligands and their application in therapy New cycloalkylalkylamines which are sigma-receptor ligands of formule (I) ##STR1## in which: R1 is H or lower alkyl; X and Y are H, OH, lower alkyl, lower alkoxy, halogen or nitrile; V1 and V2 together form a double b... | 07/05/1994 |
| 5292893 | Catalytic asymmetric and non-asymmetric reduction of times and oximes using metal catalysts A process is provided for catalytically reducing imines, oximes, hydrazones and related compounds. Moreover, there is provided a process for the catalytic asymmetric reduction of imines, oximes, hydrazones, and the like, using enantiomerically enriched ca... | 03/08/1994 |
| 5225595 | Arylsulfonyl compounds with unsaturated radicals Sulfonyl compounds of the formula ##STR1## where Ar is the radical of a benzene or naphthalene ring, R1 and R2 are each hydrogen, substituted or unsubstituted C1 -C4 -alkyl, substituted or unsubstituted phenyl, ... | 07/06/1993 |
| 5220067 | Process for the preparation of arylethylamines and substituted arylethylamines This invention provides a process for directly preparing hydrohalide salts of arylethylamines from (-chloro--oximino)acetophenones. The process involves hydrogenation in presence of a transition metal catalyst in an organic acid in substanti... | 06/15/1993 |
| 5220066 | Process for the preparation of arylethylamines and substituted arylethylamines This invention provides a process for directly preparing arylethylamines and their salts from (-halo--oximino)acetophenones. The process involves hydrogenation in presence of a transition metal catalyst. The process is illustrated by convers... | 06/15/1993 |
| 5180746 | Aralkylamine compounds An aralkylamine compound of the formula ##STR1## wherein R1 means a hydrogen atom or a lower alkyl group; R2 means an aromatic group which may be substituted; R3 means a hydrogen atom, a lower alkyl group or an aromat... | 01/19/1993 |
| 5177112 | Substituted 2-aminotetralins Certain novel compounds having the structural formula ##STR1## wherein R2, R3 and R4 are each selected from the group consisting of H and OA; A is H or is selected from the group consisting of hydrocarbyl radicals, e.... | 01/05/1993 |
| 5175368 | Process for the preparation of arylalkylamines and substituted arylalkylamines Arylalkylamines (as the hydrochloride salt), e.g. tyramine hydrochloride, are prepared by hydrogenating substituted or unsubstituted aryl--oximinoalkyl ketones, e.g. p-hydroxyisonitroacetophenone, in either in an aqueous reaction medium comprising ... | 12/29/1992 |
| 5166438 | 1,3-pentadiene derivatives and electrophotographic photoconductor using the same A charge transporting material comprising a 1,3-pentadiene derivative having formula (I): A--CH.dbd.CH--CH.dbd.CH--CH2 --A (I) wherein A represents a 9-anthryl group which may have a substituent, a N-substituted carbazolyl group... | 11/24/1992 |
| 5011998 | Aromatic tertiary amines, enamines, deoxybenzoins and benzils A novel synthesis of aromatic tertiary amines involves reacting an aromatic anil and an aromatic ether in a molar ratio of 1:1; adjusting the ratio to 2:1 produces novel enamines and by employing a two step process for enamine production, various unsymmet... | 04/30/1991 |
| 4996235 | 3,4-diphenylbutanamines The present invention provides 3,4-diphenylbutanamines capable of selectively inhibiting the uptake of serotonin and norepinephrine.... | 02/26/1991 |
| 4980354 | Tetrahydronaphthalene and indane derivatives The invention relates to tetrahydronaphthalene and indane derivatives with the general formula I: ##STR1## wherein R1 represents zero to four substituents, which may be the same or different and are selected from OH, halogen, NO2 | 12/25/1990 |
| 4968679 | 8-substituted 2-aminotetralins New 8-substituted 2-aminotetralins can be prepared from the corresponding aminotetralins or tetralones. They can be used in medicaments.... | 11/06/1990 |
| 4804406 | ଲ-naphthylalkylamines Fungicidally active novel ଲ-naphthylalkylamines of the formula ##STR1## in which Ar represents optionally substituted ଲ-naphthyl and R1 and R2, which can be identical or different, represent alkyl or alkenyl or R1 | 02/14/1989 |
| 4792628 | Indane derivatives and salts thereof Indane derivatives and their salts represented by the general formula (1), ##STR1## wherein R1 is an amino group which may have lower alkyl groups as the substituents, a hydroxylimino group, an alkanoylamino group having 1 to 10 carbon ato... | 12/20/1988 |
| 4680310 | Tetrahydronaphthalene derivatives Tetrahydronaphthalene derivatives of the formula ##STR1## wherein Y, m, n, R and R1 to R9 are as set forth herein, are described. These compounds have a pronounced calcium-antagonistic and anti-arrhythmic activity and can accord... | 07/14/1987 |